-+ 0.00%
-+ 0.00%
-+ 0.00%

PTC THERAPEUTICS ANNOUNCES APPROVAL OF SEPHIENCE™ (SEPIAPTERIN) FOR THE TREATMENT OF CHILDREN AND ADULTS LIVING WITH PHENYLKETONURIA (PKU) IN JAPAN

Reuters·12/22/2025 12:00:01

Please log in to view news